Recombinant interferon-α2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial-Reference-Cited by-同舟云学术

Recombinant interferon-α2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial

Published:2009-09 Issue:41 Volume:27 Page:5654-5660
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Miquilena-Colina María E.,Lozano-Rodríguez Tamara,García-Pozo Leonor,Sáez Alicia,Rizza Paola,Capone Imerio,Rapicetta Maria,Chionne Paola,Capobianchi Maria,Selleri Marina,Castilletti Concetta,Belardelli Filippo,Iacono Oreste Lo,García-Monzón Carmelo

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference34 articles.

1. Hepatitis B virus infection—natural history and clinical consequences;Ganem;N Engl J Med,2004

2. Status of hepatitis B immunization programmes in 1998;Kane;Vaccine,1998

3. Global control of hepatitis B virus infection;Kao;Lancet Infect Dis,2002

4. Active hepatitis B vaccination of dialysis patients and medical staff;Köhler;Kidney Int,1984

5. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy;Stevens;N Engl J Med,1984

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in renal function in CHB patients with Peg-IFN combined with nucleos(t)ide analogs;2024-05-10

2. Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience;Frontiers in Microbiology;2022-10-18

3. The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation;Biology;2021-09-01

4. Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial;Clinics and Research in Hepatology and Gastroenterology;2020-11

5. Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?;Cytokine & Growth Factor Reviews;2020-08